Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Clinical trial NCT07244003 · RECRUITING
Trial details
- NCT number
- NCT07244003
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-29
- Primary completion
- 2027-12-31
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.